 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
France's Theradiag Buys microRNA Diagnostics Shop Prestizia
June 28, 2012
France's Theradiag Buys microRNA Diagnostics Shop Prestizia
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Theradiag Expanding microRNA Assay Plans with HIV, Anti-Obesity CDx Agreement
May 2, 2013 / Gene Silencing News - NIH To Fund Projects to ID miRNA Cancer Markers, Study Role of ncRNAs in HIV-Associated Disorders
July 12, 2012 / Gene Silencing News - Theradiag Receives $1.6M to Develop Test Kits for HIV/AIDS, Obesity Project
April 9, 2013 / GenomeWeb Daily News - NIH to Fund Nanoparticle-Based RNAi Cancer Drug Development, miRNA Biomarker Discovery
August 23, 2012 / Gene Silencing News - Rosetta, Precision Therapeutics Reach Co-marketing Deal for miRview mets2 Assay
July 24, 2012 / GenomeWeb Daily News